ESMO-Congress-2020-1000x250

To get up to speed with your preparation for ESMO 2020, please download our Industry Guidelines.

Third-party media activities

Media activities initiated by third parties during or in connection with ESMO 2020, including, but not limited to:

  • Meetings such as press conferences, media briefings, educational sessions for media representatives, as well as
  • PR activities, such as press releases, news, articles, interviews, etc.

are subject to the ESMO 2020 Policy on Third-Party Media Activities. This policy aims to guarantee proper and correct distribution of oncology and cancer-related information to media representatives in connection with the conference.

Press events in or outside the congress centre but concomitant with/or during breaks of the scientific programme of ESMO 2020 are subject to ESMO Press Office approval. Please contact media@esmo.org

Official Italian Agency for AIFA Procedure

AIFA rules are mandatory only for Italian Pharmaceutical Companies that will attend a congress abroad.

Any pharmaceutical company supporting or participating in a congress, is subjected to an authorisation by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124). The request of authorisation must be submitted within 60 days before the starting date of the event.

ESMO advises pharmaceutical companies to contact the Official Agency:

AIM Group International – AIM Education S.r.l.
Contact: Cristina Ghidoli
Via G. Ripamonti, 129 
20141 Milan, Italy
Tel. +39 02 56601.1
FAX +39 02-70048585
E-mail: aifa@aimgroup.eu

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings